D

Drugs for Neglected Diseases initiative - DNDi

384 employees

Drugs for Neglected Diseases initiative is a collaborative, patients’ needs-driven, non-profit drug research and development organization

Basic info

Industry

research services

Sectors

Biotechnology
Non Profit
ntds
hepatitis C
neglected diseases
drug development
Chagas disease
medicine
malaria
leishmaniasis
dengue
research
paediatric HIV
R&D
neglected tropical diseases
open innovation
not-for-profit
Medical
human African trypanosomiasis
mycetoma
filarial diseases

Date founded

2003

Funding rounds raised

D

Drugs for Neglected Diseases initiative - DNDi raised undisclosed on September 28, 2020

Investors: Fundación Bancaria ”la Caixa”

FAQ